Table 1.
Overall Population (N = 19) | ||
---|---|---|
Mean Age at presentation | Years | 75.30 (82.02 - 67.33) |
Gender | Male | 9.00 (47.37%) |
Female | 10.00 (52.63%) | |
Smoking exposure | Yes | 5.00 (26.32%) |
No | 14.00 (73.68%) | |
Heat exposure | Yes | 2.00 (10.53%) |
No | 17.00 (89.47%) | |
Sun exposure | Yes | 6.00 (31.58%) |
No | 13.00 (68.42%) | |
Family history of malignancy | Yes | 2.00 (10.53%) |
No | 17.00 (89.47%) | |
Light phenotype | Yes | 1.00 (5.26%) |
No | 18.00 (94.74%) | |
Previous malignancies | Yes | 1.00 (5.26%) |
No | 18.00 (94.74%) | |
Histotype | BCC | 8.00 (42.11%) |
MC | 2.00 (10.53%) | |
SCC | 2.00 (10.53%) | |
SCCc | 3.00 (15.79%) | |
SGC | 4.00 (21.05%) | |
T staging | T2c | 5.00 (26.32%) |
T3b | 1.00 (5.26%) | |
T3c | 7.00 (36.84%) | |
T4a | 6.00 (31.58%) | |
Time between histology and IRT (weeks) | 21.43 (38.72–12.24) | |
Time between IRT and follow-up (weeks) | 30.00 (89.64–15.64) | |
Mortality rate | Yes | 1.00 (5.26%) |
No | 18.00 (94.74%) |